NEW YORK (GenomeWeb News) – Myriad Genetics said after the close of the market on Tuesday that revenues for the first quarter of its Fiscal Year 2014 grew 52 percent year over year, aided by publicity surrounding Angelina Jolie's use of the BRACAnalysis test.

The Salt Lake City-based company posted revenues of $202.5 million for the three months ended Sept. 30, up from $133.4 million a year ago, and topping the average analyst estimate of $167.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.